Drug interactions information

The calcium channel blocker mibefradil (Posicor ) was removed from the market in 1998. The headline for the Pink Sheets article describing this action was "Posicor Withdrawal Reflects Complexity of Interaction Profile" (59). Products identified as potentially dangerous in combination with mibefradil included cardiac drugs, such as amiodarone, flecainide, and propafenone oncologic products, such as tamoxifen, cyclophosphamide, etoposide, ifosfamide, and vinblastine and the immunosuppressant medications cyclosporine and tacrolimus. The sponsor s decision to withdraw mibefradil was based on the complexity of the drug interaction information that would have to be communicated to ensure safe usage. 

First DataBank s Evaluations of Drug Interactions (EDI) provides the most comprehensive printed source of drug-drug interaction information available. Containing interactions on both prescription and over-the-counter drugs, this two-volume loose-leaf textbook of drug monographs is the only source endorsed by the American Pharmaceutical Association. 

Drug-Reax Drug interaction information on over 8000 pharmaceuticals. 

The need to gather and assess drug interaction information and to transfer this information to physicians and pharmacists experienced a m or advance when the American Pharmaceutical Association (APhA) evaluated the best way to disseminate DDI information to practitioners. Their analysis identified the following key desirable features of DDI monographs ... 

Cranberry juice has long been recommended for use in treating and preventing urinary tract infections (UTIs). Clinical studies have confirmed that cranberry juice is beneficial to individuals with frequent UTIs Cranberries inhibit bacteria from attaching to the walls of the urinary tract and prevent certain bacteria from forming dental plaque in the mouth. Cranberry juice is safe for use asa food and for urinary tract health. Cranberry juice and capsules have no contraindica-tions no known adverse reactions and no drug interactions The recommended dosage is9 to 15 capsules a day (400-500 mg/d) or 4 to 8 ounces of juice per day. (See Chap. 6 for more information.)... 

Please outline any concomitant medications that are permitted for the duration of the trial. If the medicinal product (s) is currently licensed it is recommended that the current summary of producf characteristics (Previously known as the data sheet) is consulted for information on potential drug interactions. 

Molecular study of lipid bilayer interfaces is necessary for a better understanding of the membrane-drug interaction and DD into biomembranes. The points to be clarified are (1) How can we determine DD sites at the bilayer interface (2) What kind of method is advantageous (3) Is it possible to unambiguously specify the bilayer interfacial portion coupled with drugs (4) What are most important characteristics of DD at the bilayer interface In order to answer these important questions, this chapter has been planned. We will emphasize the significance of the molecular level information obtainable from NMR studies. 

The contents of this handbook should be utilized as a guide and in addition to sound clinical judgment. Consult full prescribing information and take into consideration each drug s pharmacokinetic profile, contraindications, warnings, precautions, adverse reactions, potential drug interactions, and monitoring parameters before use. 

Inform the patient about the potential drug-drug interactions with warfarin, including over-the-counter medications and dietary supplements (Tables 7-8, 7-9, and 7-10). Instruct the patient to call the health care practitioner responsible for monitoring warfarin therapy before starting any new medications or dietary supplements. 

For patients receiving oral antibiotics either prophylacti-cally or as treatment of febrile neutropenia, counsel them that initial or persistent fever should be reported promptly and that compliance with the regimen is critical. Patients also should have easy access to medical care and adequate caregiver support. Provide information on drug interactions and adverse effects. 

Does the resource cover the following information indication, mechanism of action, contraindications/precautions, side effects, drug interactions, and dose ... 

The latest information on drug interactions of antiretroviral drugs should be consulted. 

For more information on the side effects, pharmacokinetics, and drug interactions of specific agents, refer to Chap. 71 on Schizophrenia, Chap. 70 on Major Depressive Disorder, and Chap. 52 on Epilepsy. 

The drug interaction literature should be consulted for detailed information concerning any real or potential drug interaction involving any psychotherapeutic agent. 

Drug Levels in Plasma. Drug levels may also be measured in a clinical trial. Such levels are usually part of a pharmacokinetic analysis but also provide important safety data. This information would be particularly relevant in cases of suspected or actual drug overdosage, drug interactions, to correlate medicine levels with toxic events, or in other situations. It must be clarified whether free levels of the drug and/or the protein bound will be measured by the laboratory. 

---